This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nonn, L.
Right arrow Articles by Powis, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nonn, L.
Right arrow Articles by Powis, G.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, February 2003, p. 916-922, Vol. 23, No. 3
0270-7306/03/$08.00+0     DOI: 10.1128/MCB.23.3.916-922.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

The Absence of Mitochondrial Thioredoxin 2 Causes Massive Apoptosis, Exencephaly, and Early Embryonic Lethality in Homozygous Mice

Larisa Nonn,* Ryan R. Williams, Robert P. Erickson, and Garth Powis*

Arizona Cancer Center, University of Arizona, Tucson, Arizona 85714-5024

Received 13 September 2002/ Returned for modification 2 October 2002/ Accepted 7 November 2002


arrow
ABSTRACT
 
Thioredoxin 2 (Trx-2) is a small redox protein containing the thioredoxin active site Trp-Cys-Gly-Pro-Cys that is localized to the mitochondria by a mitochondrial leader sequence and encoded by a nuclear gene (Trx-2). Trx-2 plays an important role in cell viability and the regulation of apoptosis in vitro. To investigate the role of Trx-2 in mouse development, we studied the phenotype of mice that have the Trx-2 gene silenced by mutational insertion. Homozygous mutant embryos do not survive to birth and die after implantation at Theiler stage 15/16. The homozygous mutant embryos display an open anterior neural tube and show massively increased apoptosis at 10.5 days postcoitus and are not present by 12.5 days postcoitus. The timing of the embryonic lethality coincides with the maturation of the mitochondria, since they begin oxidative phosphorylation during this stage of embryogenesis. In addition, embryonic fibroblasts cultured from homozygous Trx-2-null embryos were not viable. Heterozygous mice are fertile and have no discernible phenotype visible by external observation, despite having decreased Trx-2 mRNA and protein. These results show that the mitochondrial redox protein Trx-2 is required for normal development of the mouse embryo and for actively respiring cells.


arrow
INTRODUCTION
 
The mitochondria are a critical site of reactive oxygen species (ROS) production within the cell. The electron transport chains within the mitochondria consume oxygen to produce water and cellular energy in the form of adenosine triphosphate. During this process of oxidative phosphorylation between 0.4 and 4% of the consumed oxygen is released in the mitochondria as ROS (3). Regulated ROS production is involved in receptor mediated cell signaling pathways, transcriptional activation, and normal cell proliferation (13, 25). ROS production is essential for normal mouse embryogenesis, and an increase in ROS of specific cells mediates the apoptosis that is required for cell elimination during embryonic morphogenesis (23).

If the redox balance of the cell is compromised, increased ROS production can cause detrimental oxidative damage to biological molecules. Aberrant increases in ROS within the mitochondria can induce apoptosis by causing the release of proapoptotic factors, including cytochrome c and apoptosis-inducing factor, via the opening of a nonselective pore (19, 27, 33). ROS-induced oxidative damage to the mitochondria has been implicated in aging and the pathology of a number of degenerative diseases (31).

The mitochondria contain antioxidant defenses that protect against ROS-induced damage, including manganese superoxide dismutase (MnSOD/SOD-2) (18), mitochondrial glutaredoxin (Grx2a) (11), glutathione/phospholipid hydroperoxide glutathione peroxidase (GSH/PHGPX [GPX4]) (16), catalase (22), and the thioredoxin 2 (Trx-2) system (21). The Trx-2 system, Grx2a, and MnSOD are mitochondrion-specific proteins, whereas GSH/PHGPX and catalase are present in other parts of the cell (11, 16, 18, 21, 22). In the MnSOD knockout mouse, the neonates die by age 10 days of neurodegeneration and dilated cardiomyopathy (18).

The Trx-2 (Trx-2 in mice; TRX-2 in humans) system includes Trx-2, mitochondrial thioredoxin reductase 2 (TrxR-2), and mitochondrial peroxiredoxin 3 (Prdx-3) (6, 7, 20, 26). Trx-2 is a member of the thioredoxin (Trx) family of small redox proteins that contain a conserved active site of Trp-Cys-Gly-Pro-Cys-Lys (26). The active-site cysteines of thioredoxins function to maintain protein thiols in a reduced state by becoming oxidized themselves. TrxR-2 regenerates Trx-2 by reducing the oxidized active site cysteines (20). Prdx-3 is a thioredoxin peroxidase that utilizes Trx-2 as an electron donor for the reduction of hydrogen peroxide (5). Trx-2, TrxR-2, and Prdx-3 proteins are each encoded in the nuclear genome and contain a mitochondrial leader sequence that is cleaved off after import of the protein into the mitochondria. The mitochondrial Trx-2 system is ubiquitously expressed, but it is found at the highest levels in the metabolically active tissues of the heart, brain, and liver (5, 20, 26).

Recent studies have shown that Trx-2 overexpression in vitro can protect the cell against t-butylhydroperoxide and etoposide-induced apoptosis, as well as increasing the mitochondrial membrane potential ({Delta}{Psi}) (8, 9). In addition, cells deficient in Trx-2 display increased cellular ROS and apoptosis (28).

We have examined the role of the Trx-2 system in mammalian development by generating a mouse deficient in Trx-2. The Trx-2+/- heterozygous mice appeared normal even though they displayed decreased levels of Trx-2, whereas early embryonic lethality was seen in the Trx-2-/- homozygous embryos.


arrow
MATERIALS AND METHODS
 
Chemicals and reagents. All chemicals and reagents were supplied by Sigma-Aldrich (St. Louis, Mo.) unless otherwise stated.

Generation of Trx-2+/- heterozygous mice. Founder mice were created by Lexicon Genetics (The Woodlands, Tex.) and developed by gene trapping by using random insertional mutagenesis with retroviral vector VICTR24 as described by Zambrowicz et al. (32). VICTR24 was generated by cloning a sequence acquisition component and a mutagenic component into the pGen sup- expression vector, followed by packaging by GP+E86 cells. The acquisition component consists of phosphoglycerate kinase 1 promoter (PGK) fused to the neomycin resistance gene, followed by a synthetic consensus splice donor sequence (PGK-neo-SD), and the mutagenic component is a splice acceptor sequence fused to a colorometric marker, followed by a polyadenylation sequence (SA-bgeo-pA). Embryonic stem cells were retrovirally infected with VICTR24 and clonally selected. The presence of only one gene copy of the mutational insertion was verified by quality control, and the sequence of the trapped gene was obtained for each clone by 3' rapid amplification of cDNA ends. The mouse Trx-2 cDNA sequence was used to screen the Lexicon OmniBank library database of disrupted genes (http://www.lexgen.com). Clone OST69169, in which the mutational insertion is 301 bp upstream of Trx-2 exon 1, was utilized to prevent transcription of Trx-2. The embryonic stem cells were injected into C57BL/6 blastocysts and implanted into pseudopregnant females. Chimeric pups were bred to generate heterozygous offspring.

Genotyping. Mice were maintained on NIH-31 modified irradiated rat and mouse chow (Harlan Techlad, Indianapolis, Ind.) and bottled water ad libitum. Mice were tail tipped and ear tagged at 3 weeks. DNA was extracted by using a DNeasy kit (Qiagen, Valencia, Calif.). For genotyping of formalin-fixed and paraffin-embedded embryos, embryonic tissue was scraped from unstained sections and deparaffinized prior to DNA extraction with the DNeasy kit. Genotyping was done by using two PCRs. One PCR for the insert was performed with a 5' primer within the LTR2 insertion (5'-AAATGGCGTTACTTAAGCTAGCTTGC-3') and a 3' primer in chromosome 15 downstream of the insertion (5'-GGCATGCAATAGGAAGTCACAC-3'). A second PCR was performed with a 5' primer in chromosome 15 upstream of the insertion (5'-CCTTCTAACTTAACGTCTATTCAGT-3') and a 3' primer in chromosome 15 downstream of the insertion (5'-GGCATGCAATAGGAAGTCACAC -3'). To aid in primer design, the LTR2 5' and chromosome 15 flanking sequences were provided by Lexicon Genetics. PCR products were visualized by using agarose gel electrophoresis and staining with ethidium bromide.

Timed pregnancies. Female heterozygous mice, 6 to 10 weeks of age, were bred to heterozygous males. Pregnant females were sacrificed by cervical dislocation 12.5, 10.5, 9.5, and 8.5 days after the day of observing a vaginal plug. Uteri and embryos were removed for genotyping, Western blotting, or immunohistochemistry.

Mouse embryo fibroblasts. Embryos from a heterozygous mating were collected at 9.5 days postcoitus (dpc). Embryos were dissected from deciduum and individually incubated in trypsin for 5 min at 37°C. Cells were pipetted up and down, followed by two washes with phosphate-buffered saline. Small samples were reserved for DNA preparation and genotyping. Cells were plated in high-glucose Dulbecco modified Eagle medium supplemented with fetal bovine serum (20%), L-glutamine (2 µM), sodium pyruvate (1 mM), penicillin (50 IU/ml), and streptomycin sulfate (50 µg/ml) and then maintained at 37°C in 5% CO2.

Antibody generation. TRX-2 was fused to maltose-binding protein by cloning into the pMAL prokaryotic expression vector (Invitrogen, Carlsbad, Calif.). Recombinant TRX-2/maltose-binding protein was expressed in Escherichia coli, purified by using a maltose column, and injected into 8-week-old male New Zealand White rabbits (Jackson Laboratories, Bar Harbor, Maine) to generate polyclonal antisera. Rabbit polyclonal antisera to a unique peptide sequence from {Delta}TRXR-2 and to a unique peptide sequence from PRDX-3 (SPAASKEYFQKVNQ; Alpha Diagnostic, San Antonio, Tex.) were generated in a similar manner. These polyclonal antibodies to TRX-2, TRXR-2, and PRDX-3 all cross-reacted with the mouse proteins.

Mitochondrion isolation. Hepatic mitochondria were isolated by a modification of the method of Bustamante et al. (4). Briefly, mice were sacrificed by carbon dioxide asphyxiation, and their livers were removed. The livers were minced on ice, followed by homogenization with a Teflon pestle for six strokes in ice-cold MSH buffer (250 mM mannitol, 75 mM sucrose, 5 mM HEPES; pH 7.4) with 1 mM EDTA. The homogenates were immediately centrifuged for 10 min at 600 x g and 4°C; the supernatant was then transferred to a prechilled tube and centrifuged for 15 min at 6,800 x g and 4°C. The pellet was resuspended in ice-cold MSH buffer and centrifuged for 10 min at 600 x g and 4°C. The supernatant was centrifuged for 15 min at 6,800 x g and 4°C, and the mitochondrial pellet was resuspended in MSH buffer for electrophoresis and Western blot analysis (100 µg). Protein was quantified by using the Bio-Rad protein reagent (Bio-Rad, Hercules, Calif.).

Western blot analysis of mouse tissues. Heterozygous and wild-type mice at 6 to 10 weeks of age were sacrificed by cervical dislocation. Brain, liver, heart, lung, and kidney tissues were excised and placed in ice-cold lysis buffer (0.5% Nonidet P-40, 0.5% sodium deoxycholate, 50 mM NaCl, 1 mM EDTA, 1 mM NaVO3, 50 mM HEPES [pH 7.5], 1 mM phenylmethylsulfonyl fluoride). Tissue samples were homogenized on ice with a PowerGen 35 (Fisher Scientific, Pittsburgh, Pa.). The tissue lysates were snap-frozen in a dry-ice ethanol bath and then thawed on ice. Lysates were cleared by centrifugation (10,000 x g) for 15 min at 4°C. Protein was quantified by using Bio-Rad protein reagent. Cleared tissue lysate (20 µg) was loaded onto a 10% NuPAGE gel (Invitrogen). The proteins were separated by electrophoresis and then transferred to polyvinylidene difluoride membrane (NEN, Boston, Mass.). Antibodies used in Western blotting were anti-TRX-2, TRXR-2, or PRDX-3 rabbit polyclonal antisera, anti-human MnSOD monoclonal antibody (Upstate Biochemicals, Lake Placid, N.Y.), and anti-bovine catalase rabbit polyclonal antibody (Rockland, Gilbertsville, Pa.), followed by the addition of horseradish peroxidase-conjugated anti-rabbit or anti-mouse secondary antibody. The results were visualized by Western Lightning chemiluminescence (NEN), followed by autoradiography.

RNA purification and Northern blot analysis. Liver total RNA was extracted by using Trizol Reagent (Invitrogen) and the PowerGen 35 homogenizer. Poly(A) RNA was purified from 500 µg of total RNA by using Oligotex beads (Qiagen). Poly(A) RNA (2 µg) was separated by electrophoresis on a 1.2% agarose gel, and RNA was transferred to nitrocellulose (Osmonics) for Northern blot analysis. cDNA probes were radiolabeled with [{alpha}-32P]dCTP (NEN) by using the random prime labeling kit (Invitrogen). Blots were hybridized with radiolabeled probes overnight at 42°C in UltraHyb buffer (Ambion, Austin, Tex.). Nonspecific probe was removed by a series of washes. Northern blots were visualized by using autoradiography and a Molecular Dynamics PhosphorImager (Amersham Biosciences, Piscataway, N.J.) and then quantified by using ImageQuant software.

Immunohistochemistry. Embryos from 12.5-, 10.5-, 9.5-, and 8.5-dpc pregnant females were fixed in 4% formaldehyde in phosphate-buffered saline for 24 h prior to being routinely processed and embedded in paraffin. Tissues were serially sectioned at 4 µm and deparaffinized through xylene and graded alcohols prior to blocking. Sections were incubated with mouse anti-caspase-3 (Trevigen, Gaithersburg Md.) for 32 min at 42°C on a Ventana ES (Ventana Medical Systems, Tucson, Ariz.) automated slide stainer and then visualized by using the basic DAB detection kit (Ventana Medical Systems). Stained slides were dehydrated through graded alcohols and xylene prior to coverslipping. Certain sections were stained with a modified Harris' hematoxylin and eosin as morphological references.


arrow
RESULTS AND DISCUSSION
 
Lethality of Trx-2-deficient embryos and fibroblasts. Trx-2 is encoded by a single nuclear gene on mouse chromosome 15 (A. Miranda-Vizuete, A. Gustaffsson, and G. Spyrou, NCBI database entry MMU85089, 1997 [unpublished data]). Disruption of Trx-2 transcription was achieved by the retroviral insertion of a gene trap 301 bp upstream of exon 1 (Fig. 1A). A single copy of the insertion was previously verified in the embryonic stem cells prior to microinjection by using Quality Control from Lexicon. Genotyping of the offspring was performed by using two PCRs (Fig. 1B). One PCR for the insert used a 5' primer within the LTR2 insertion and a 3' primer in chromosome 15 downstream of the insertion. A second PCR used a 5' primer in chromosome 15 upstream of the insertion and a 3' primer in chromosome 15 downstream of the insertion. The insertion did not cause an externally discernible phenotype in the heterozygous Trx-2+/- mice, whereas the homozygous Trx-2-null Trx-2-/- mice did not survive to birth (Table 1).



View larger version (52K):
[in this window]
[in a new window]
  		FIG. 1. Disruption of mouse Trx-2. (A) Diagram showing the three exons of the Trx-2 locus (with an arrow indicating the location of active-site cysteines) (not drawn to scale), the retroviral insertion of LTR-SA-BGEO-pA-PGK-neo-SD-LTR2 (hatched boxes) 351 bp upstream of exon 1, and the location of genotyping PCR primers A and B. (B) Genotyping of mouse DNA by two PCRs: one PCR for the mutant allele (lanes A) and one PCR for the wild-type allele (lanes B). Trx-2+/- mice are positive for both A and B, Trx2+/+ (wild-type) mice are positive only for B, and Trx-2-/- mice are positive only for A. The top bands are the specific PCR products, and the bottom bands present in all of the lanes are the primer dimer.


View this table:
[in this window]
[in a new window]
  		TABLE 1. Offspring genotypes from heterozygous matings

To determine the timing of the lethality during embryogenesis, embryos were collected from heterozygous matings at 12.5, 10.5, 9.5, and 8.5 dpc. The embryos were genotyped by PCR on DNA from embryonic tissue scraped off of unstained sections to determine the presence of mice deficient in Trx-2 (Table 1). At 12.5 dpc, we observed normal embryos as well as embryos at various stages of resorption, and none of the normal embryos were genotyped as homozygous Trx-2-/- (Table 1). Homozygous Trx-2-/- embryos were observed in the 8.5-, 9.5-, and 10.5-dpc pregnant mice. At 8.5 dpc, the embryos did not have features that distinguished their genotype, and they all appeared normal regardless of the genotype (data not shown). By 9.5 dpc the Trx-2-/- embryos displayed an open anterior neural tube when observed by microscopy (Fig. 2A and B). These embryos with the defect showed normal closure of the posterior neural tube, and the other embryonic features appeared normal except for the distortion caused by the open anterior neural tube. Staining of the 9.5-dpc embryos for apoptotic cells with anti-cleaved caspase-3 antibody showed a marked increase in apoptotic cells in the homozygous Trx-2-/- embryos compared to neighboring wild-type or heterozygous embryos (Fig. 2C and D). In the apoptotic cascade, pro-caspase-3 is cleaved after the mitochondrial cytochrome c release; thus, the presence of cleaved caspase-3 was used as a marker for apoptosis (27). At 10.5 dpc, we observed that surviving Trx-2-/- embryos had an open anterior neural tube and were smaller than their wild-type and Trx-2+/- littermates (Fig. 2E and F). Anti-caspase-3 staining of the 10.5-dpc embryos showed massive apoptosis in the Trx-2-/- embryos, whereas very few caspase-3 positive cells were detected in the wild-type and Trx-2+/- embryos (Fig. 2G and H). Western blot analysis of 9.5-dpc embryos verified that Trx-2-/- embryos did not have any detectable Trx-2 protein (Fig. 3).



View larger version (81K):
[in this window]
[in a new window]
  		FIG. 2. Anterior neural tube defect and increased apoptosis in homozygous Trx-2-/- mice at 9.5 and 10.5 dpc (representative embryos and images). Aberrant anterior neural tube closure in Trx-2-/- embryo, indicated by arrows, was compared to the wild-type embryo by hemotoxylin and eosin staining of paraffin-embedded embryos at 9.5 dpc (A and B) and at 10.5 dpc (E and F). In panels C and D are shown increased anti-cleaved caspase-3 antibody-positive cells from Trx-2-/- embryos compared to wild-type embryos by immunohistochemical staining of paraffin-embedded 9.5-dpc embryos (adjacent slices of the embryos shown in panels A and B). In panels G and H, massive apoptosis in 10.5-dpc Trx-2-/- embryos can be seen compared to the wild-type embryos as visualized by anti-caspase-3 antibody staining of paraffin-embedded embryos (adjacent slices of the embryos shown in E and F). Heavy staining in the uterine tissue is not specific to cleaved caspase-3 and is due to endogenous mouse immunoglobulin G interactions with the secondary antibody.



View larger version (32K):
[in this window]
[in a new window]
  		FIG. 3. Loss of Trx-2 protein in Trx-2-/- embryos. A Western blot analysis of Trx-2 protein in 30 µg of tissue homogenate from 9.5-dpc embryos is shown.

The results of the timed pregnancies show that complete Trx-2 deficiency in the homozygous Trx-2-/- mouse is lethal early in mouse embryonic development at ca. 10.5 dpc, Theiler stage 15/16 (15). The Trx-2-/- embryos displayed an open anterior neural tube at 9.5 and 10.5 dpc, and this may contribute to their death and resorption. Other developmental processes occurring during this stage of embryogenesis, such as enlargement of the primitive heart, septum formation, and limb bud development (15), were apparently unaffected by the Trx-2 deficiency. Once closed, the anterior neural tube develops rapidly into the brain (30). An open anterior neural tube, exencephaly, is a common neural tube defect found in a wide variety of embryonic lethal mouse knockouts (14). The high prevelance of neural tube defects in mouse knockouts shows that they are probably not due to a defect specific of the neural tube closure mechanism but instead reflective of a moribund embryo (14).

The 9.5- and 10.5-dpc Trx-2-/- embryos showed increased apoptosis when stained for cleaved caspase-3. It was not clear whether this increase in apoptosis was the cause of the embryo's death prior to resorption or the beginning stages of the resorption process itself. Trx-2 has previously been reported to be essential for cell viability in vitro, with apoptosis occurring in Trx-2-deficient cells (28). This in vitro finding did not appear to carry over to the Trx-2 knockout mouse because the Trx-2-/- embryos developed normally until day 9.5 without undergoing global apoptosis. In the developing rat embryo, it is known that at 10 to 12 dpc the mitochondria mature rapidly and begin to utilize the Krebs cycle and oxidative phosphorylation (24, 29). Although the rat and mouse have slightly different gestation times, 21 and 19 days, respectively, the embryonic developmental stages are almost identical to those of the rat, which are approximately 1 day behind the mouse (15). As the mitochondria begin to utilize oxygen at this point in embryogenesis, they would also begin to produce mitochondrial ROS. The most likely explanation for the normal appearance of Trx-2-/- embryos until 9.5 dpc is because mitochondrial ROS production is minimal prior to this stage of embryogenesis.

To further investigate the Trx-2-/- phenotype, embryonic fibroblasts were cultured from 9.5-dpc embryos. By 24 h after plating, ca. 25% of the embryos did not produce any viable fibroblasts, and these were all genotyped as homozygous Trx-2-/- (data not shown). The fibroblasts that grew were all genotyped wild-type or heterozygous Trx-2+/- (Table 1). The fibroblasts were cultured from 9.5-dpc embryos which, as previously stated, do not yet respire aerobically. When the Trx-2-/- cells are removed from the embryo and placed in routine cell culture conditions they die. These results agree with those of Tanaka et al. (28) and show the necessity of Trx-2 during cellular respiration.

Heterozygous mice have reduced protein expression of Trx-2. A decrease in Trx-2 mRNA, measured by Northern blot analysis of liver mRNA, was observed in heterozygous Trx-2+/- mice compared to wild-type mice Trx-2+/+ (Fig. 4A). Additionally, a decrease in Trx-2 protein levels, as measured by Western blot analysis, was seen in brain, liver, heart, lung, and kidney homogenates from heterozygous Trx-2+/- mice (Fig. 4B).



View larger version (19K):
[in this window]
[in a new window]
  		FIG. 4. Decrease of Trx-2 transcript/Trx-2 protein in heterozygous mice. (A) Trx-2 expression as shown by Northern blot analysis of wild-type and heterozygous Trx-2+/- mice on 2 µg of liver mRNA probed with Trx-2 and GAPDH cDNA. (B) Trx-2 protein expression in the brains, livers, hearts, lungs, and kidneys of wild-type Trx-2+/+ and heterozygous mice Trx-2+/- by Western blot of 20 µg of tissue homogenate probed with {alpha}-Trx-2 rabbit polyclonal antibody.

The heterozygous Trx-2+/- mice, at least up to 8 months of age, do not have a gross phenotype and do not display upregulation of other mitochondrial antioxidant proteins. To examine whether the decrease of Trx-2 protein expression in the heterozygous mice altered the expression of other mitochondrial antioxidant proteins, Western blot analysis was performed on Trx-2+/+ and Trx-2+/- liver mitochondrial lysates. Trx-2 and TrxR-2 protein expression was greatly reduced in the Trx-2+/- mice, whereas Prdx-3, MnSOD, and catalase levels remained unchanged (Fig. 5A). Western blot analysis of 9.5-dpc embryos showed that Trx-2-/- embryos did not have any detectable TrxR-2 protein (Fig. 5B). The decrease in TrxR-2 protein expression was further investigated by examining gene expression. Northern blot analysis revealed that TrxR-2 mRNA levels were not affected in Tax2+/- mice (Fig. 5C). Therefore, the mechanism leading to this decrease in TrxR-2 protein in response to the decrease in Trx-2 is unknown, but it appears to occur posttranscriptionally. Other members of the selenoprotein family, of which TrxR-2 is a member, have been previously been shown to be regulated posttranscriptionally by incorporation of selenium (12).



View larger version (27K):
[in this window]
[in a new window]
  		FIG. 5. Effects of decreased Trx-2 protein expression on the mitochondrial thioredoxin system, MnSOD, and catalase. (A) Western blot analysis of 20 µg of liver mitochondrial lysates from Trx-2+/+ and Trx-2+/- mice. The same blot was stripped and reprobed with antibodies to TRX-2 (14 kDa), TRXR-2 (56 kDa), PRDX-3 (22 kDa), MnSOD (24 kDa), and catalase (65 kDa). (B) Western blot analysis of TrxR-2 protein in 30 µg of tissue homogenate from 9.5-dpc embryos. (C) TrxR-2 gene expression in Trx-2+/+ and Trx-2+/- mice analyzed by Northern blot with TrxR-2 and GAPDH cDNA.

The absence of a discernible phenotype in heterozygous Trx-2+/- mice with a lethal phenotype in homozygous Trx-2-/- mice is similar to findings reported with Sod-2 knockout mice (18). Sod-2 is a mitochondrial superoxide dismutase that scavenges superoxide radical by catalytically converting it to hydrogen peroxide (18). Although heterozygous Sod-2+/- do not have a gross phenotype, they do have increased sensitivity to mitochondrial toxins, ionizing radiation, and oxygen toxicity, as well as age-related mitochondrial deficiencies (1, 2, 10, 17). Since the Sod-2+/- phenotypes were only observed under stressed conditions and the Trx-2+/- mice do not have a discernible phenotype, this suggests that mitochondrial antioxidants may be present in excess in nonmutant mice under normal conditions.


arrow
ACKNOWLEDGMENTS
 
We thank Loretta Barbercheck and Bob Hunter for invaluable help with the animal care and handling techniques.

This work was supported by a grant from the Arizona Disease Control Research Commission (G.P.) and NIH grants CA23074 (R.P.E.) and CA77204 (G.P.).


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Arizona Cancer Center, University of Arizona, 1515 N. Campbell Ave., Tucson, AZ 85724-5024. Phone: (520) 626-6408. Fax: (520) 626-4848. E-mail: gpowis{at}azcc.arizona.edu. Back


arrow
REFERENCES
 
    1
  1. Andreassen, O. A., R. J. Ferrante, A. Dedeoglu, D. W. Alber, P. Klivenyi, E. J. Carlson, C. J. Epstein, and M. F. Beal. 2001. Mice with a partial deficiency of manganese superoxide dismutase show increased vulnerability to the mitochondrial toxins malone, 3-nitropropionic acid, and MPTP. Exp. Neurol. 167:189-195.[CrossRef][Medline]
    2. 2
  2. Asikainen, T. M., T. T. Huang, E. Taskinen, A. L. Levonen, E. Carlson, R. Lapatto, C. J. Epstein, and K. O. Raivio. 2001. Increased sensitivity of homozygous Sod2 mutant mice to oxygen toxicity. Free Radic. Biol. Med. 32:175-186.
    3. 3
  3. Boveris, A. 1984. Determination of the production of superoxide radicals and hydrogen peroxide in mitochondria. Methods Enzymol. 105:429-435.[Medline]
    4. 4
  4. Bustamante, E., J. W. Sper, and P. L. Pedersen. 1977. A high-yield preparative method for isolation of rat liver mitochondria. Anal. Biochem. 80:401-408.[CrossRef][Medline]
    5. 5
  5. Chae, H. Z., H. J. Kim, S. W. Kang, and S. G. Rhee. 1999. Characterization of three isoforms of mammalian peroxiredoxin that reduce peroxides in the presence of thioredoxin. Diabetes Res. Clin. Pract. 45:101-112.[CrossRef][Medline]
    6. 6
  6. Chae, H. Z., K. Robison, L. B. Poole, G. Church, G. Storz, and S. G. Rhee. 1994. Cloning and sequencing of thiol-specific antioxidant form mammalian brain: alkyl hydroperoxide reductase and thiol-specific antioxidant define a large family of antioxidant enzymes. Proc. Natl. Acad Sci. USA 91:7017-7021.[Abstract/Free Full Text]
    7. 7
  7. Chae, H. Z., T. B. Uhm, and S. G. Rhee. 1994. Dimerization of thiol-specific antioxidant and the essential role of cysteine 47. Proc. Natl. Acad Sci. USA 91:7022-7026.[Abstract/Free Full Text]
    8. 8
  8. Chen, Y., J. Cai, T. J. Murphy, and D. P. Jones. 2002. Overexpressed human mitochondrial thioredoxin confers resistance to oxidant-induced apoptosis in human osteosarcoma cells. J. Biol. Chem. 277:33242-33248.
    9. 9
  9. Damdimopoulos, A. E., A. Miranda-Vizuete, M. Pelto-Huikko, A. Gustafsson, and G. Spyrou. 2002. Human mitochondrial thioredoxin: involvement in mitochondrial membrane potential and cell death. J. Biol. Chem. 277:33249-33257.
    10. 10
  10. Epperly, M. W., C. J. Epstein, E. L. Travis, and J. S. Greenberger. 2000. Decrease pulmonary radiation resistance of manganese superoxide dismutase (MnSOD)-deficient mice is corrected by human manganese superoxide dismutase-plasmid/liposome (SOD2-PL) intratracheal gene therapy. Radiat. Res. 154:365-374.[CrossRef][Medline]
    11. 11
  11. Gladyshev, V. N., A. Liu, S. V. Novoselov, K. Krysan, Q. A. Sun, V. M. Kryudov, G. V. Kryukov, and M. F. Lou. 2001. Identification and characterization of a new mammalian glutaredoxin (thioltransferase), Grx2. J. Biol. Chem. 276:30374-30380.[Abstract/Free Full Text]
    12. 12
  12. Hadly, K. B., and R. A. Sunde. 2001. Selenium regulation of thioredoxin reductase activity and mRNA levels in rat liver. J. Nutr. Biochem. 12:693-703.[CrossRef][Medline]
    13. 13
  13. Huang, R. P., J. X. Wu, Y. Fan, and E. D. Adamson. 1996. UV activates growth factor receptors via reactive oxygen species. J. Cell Biol. 133:211-220.[Abstract/Free Full Text]
    14. 14
  14. Juriloff, D. M., and M. J. Harris. 1999. Mini-review: toward understanding mechanisms of genetic neural tube defects in mice. Teratology 60:292-305.[CrossRef][Medline]
    15. 15
  15. Kaufman, M. H. 1999. The atlas of mouse development. Academic Press, Inc., San Diego, Calif.
    16. 16
  16. Knopp, E. A., T. L. Arndt, K. L. Eng, M. Caldwell, R. C. Leboef, S. S. Deeb, and K. D. O'Brien. 1999. Murine phospholipids hydroperoxide glutathione peroxidase: cDNA sequence, tissue expression, and mapping. Mamm. Genome 10:601-605.[CrossRef][Medline]
    17. 17
  17. Kokoszka, J. E., P. Coskun, L. A. Esposito, and D. C. Wallace. 2001. Increased mitochondrial oxidative stress in the Sod2+/- mouse results in age-related decline of mitochondrial function culminating in increased apoptosis. Proc. Natl. Acad Sci. USA 98:2278-2283.[Abstract/Free Full Text]
    18. 18
  18. Li, Y., T. T. Huang, E. J. Carlson, S. Melov, P. C. Ursell, J. L. Olson, L. J. Noble, M. P. Yoshimura, C. Berger, P. H. Chan, D. C. Wallace, and C. J. Epstein. 1995. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat. Genet. 11:376-381.[CrossRef][Medline]
    19. 19
  19. Lui, X., C. N. Kim, J. Yang, R. Jemmerson, and X. Wang. 1996. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86:147-157.[CrossRef][Medline]
    20. 20
  20. Miranda-Vizuete, A., A. E. Damdimopoulos, and G. Spyrou. 1999. cDNA cloning, expression, and chromosomal localization of the mouse mitochondrial thioredoxin reductase gene (1). Biochim. Biophys. Acta 1447:113-118.[Medline]
    21. 21
  21. Miranda-Vizuete, A., A. E. Damdimopoulos, and G. Spyrou. 2000. The mitochondrial thioredoxin system. Antioxid. Redox Signal 2:801-810.[Medline]
    22. 22
  22. Radi, R., J. F. Turrens, L. Y. Change, K. M. Bush, J. D. Crapo, and B. A. Freeman. 1991. Detection of catalase in rat heart mitochondria. J. Biol. Chem. 266:22022-22028.
    23. 23
  23. Salas-Vidal, E., H. Lomeli, S. Castro-Obregon, R. Cuervo, D. Escalante-Alcalde, and L. Covarrubias. 1998. Reactive oxygen species participate in the control of mouse embryonic cell death. Exp. Cell Res. 238:136-147.[CrossRef][Medline]
    24. 24
  24. Shepard, T. H., L. A. Muffley, and L. T. Smith. 1998. Ultrastructural study of mitochondria and their cristea in embryonic rats and primate. Anat. Rec. 252:383-392.[CrossRef][Medline]
    25. 25
  25. Simon, H. U., A. Yehia-Haj, and F. Levi-Schaffer. 2000. Role of reactive oxygen species (ROS) in apoptosis function. Apoptosis 5:415-418.[CrossRef][Medline]
    26. 26
  26. Spyrou, G., E. Enmark, A. Miranda-Vizuete, and J. Gustafsson. 1997. Cloning and expression of a novel mammalian thioredoxin. J. Biol. Chem. 272:2936-2941.[Abstract/Free Full Text]
    27. 27
  27. Susin, S. A., N. Zamzami, M. Castedo, T. Hirsch, P. Marchetti, A. Macho, E. Daugas, M. Geuskens, and G. Kroemer. 1996. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J. Exp. Med. 184:1331-1341.[Abstract/Free Full Text]
    28. 28
  28. Tanaka, T., F. Hosoi, Y. Yamguchi-Iwai, H. Nakmura, H. Masutani, S. Ueda, A. Nishiyama, S. Takeda, H. Wada, G. Spyrou, and J. Yodoi. 2002. Thioredoxin-2 (TRX-2) is an essential gene regulating mitochondria-dependent apoptosis. EMBO 21:1695-1703.[CrossRef][Medline]
    29. 29
  29. Tanimura, T., and T. H. Shepard. 1970. Glucose metabolism by rat embryos in vitro. Proc. Soc. Exp. Biol. Med. 135:51-54.[CrossRef][Medline]
    30. 30
  30. Theiler, K. 1972. The house mouse. Springer-Verlag, Berlin, Germany.
    31. 31
  31. Van Remmen, H., and A. Richardson. 2001. Oxidative damage to mitochondria and aging. Exp. Gerontol. 36:957-968.[CrossRef][Medline]
    32. 32
  32. Zambrowicz, B. P., G. A. Fredrich, E. C. Buxton, S. L. Lilleberg, C. Person, and A. T. Sands. 1998. Disruption and sequence identification of 2,000 genes in mouse embryonic stem cells. Nature 392:608-611.[CrossRef][Medline]
    33. 33
  33. Zoratti, M., and I. Szabo. 1995. The mitochondrial permeability transition. Biochim. Biophys. Acta 1241:139-176.[Medline]

Molecular and Cellular Biology, February 2003, p. 916-922, Vol. 23, No. 3
0270-7306/03/$08.00+0     DOI: 10.1128/MCB.23.3.916-922.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Zhang, Y., Ikeno, Y., Qi, W., Chaudhuri, A., Li, Y., Bokov, A., Thorpe, S. R., Baynes, J. W., Epstein, C., Richardson, A., Van Remmen, H. (2009). Mice Deficient in Both Mn Superoxide Dismutase and Glutathione Peroxidase-1 Have Increased Oxidative Damage and a Greater Incidence of Pathology but No Reduction in Longevity. J Gerontol A Biol Sci Med Sci 64A: 1212-1220 [Abstract] [Full Text]  
  • Bernal-Bayard, J., Ramos-Morales, F. (2009). Salmonella Type III Secretion Effector SlrP Is an E3 Ubiquitin Ligase for Mammalian Thioredoxin. J. Biol. Chem. 284: 27587-27595 [Abstract] [Full Text]  
  • Luan, R., Liu, S., Yin, T., Lau, W. B., Wang, Q., Guo, W., Wang, H., Tao, L. (2009). High glucose sensitizes adult cardiomyocytes to ischaemia/reperfusion injury through nitrative thioredoxin inactivation. Cardiovasc Res 83: 294-302 [Abstract] [Full Text]  
  • Greetham, D., Grant, C. M. (2009). Antioxidant Activity of the Yeast Mitochondrial One-Cys Peroxiredoxin Is Dependent on Thioredoxin Reductase and Glutathione In Vivo. Mol. Cell. Biol. 29: 3229-3240 [Abstract] [Full Text]  
  • Barkic, M., Crnomarkovic, S., Grabusic, K., Bogetic, I., Panic, L., Tamarut, S., Cokaric, M., Jeric, I., Vidak, S., Volarevic, S. (2009). The p53 Tumor Suppressor Causes Congenital Malformations in Rpl24-Deficient Mice and Promotes Their Survival. Mol. Cell. Biol. 29: 2489-2504 [Abstract] [Full Text]  
  • Dai, S., He, Y., Zhang, H., Yu, L., Wan, T., Xu, Z., Jones, D., Chen, H., Min, W. (2009). Endothelial-Specific Expression of Mitochondrial Thioredoxin Promotes Ischemia-Mediated Arteriogenesis and Angiogenesis. Arterioscler. Thromb. Vasc. Bio. 29: 495-502 [Abstract] [Full Text]  
  • Song, J.-Y., Kim, K.-D., Roe, J.-H. (2008). Thiol-Independent Action of Mitochondrial Thioredoxin To Support the Urea Cycle of Arginine Biosynthesis in Schizosaccharomyces pombe. Eukaryot Cell 7: 2160-2167 [Abstract] [Full Text]  
  • Bentley, A R, Emrani, P, Cassano, P A (2008). Genetic variation and gene expression in antioxidant related enzymes and risk of COPD: a systematic review. Thorax 63: 956-961 [Abstract] [Full Text]  
  • He, M., Cai, J., Go, Y.-M., Johnson, J. M., Martin, W. D., Hansen, J. M., Jones, D. P. (2008). Identification of Thioredoxin-2 as a Regulator of the Mitochondrial Permeability Transition. Toxicol Sci 105: 44-50 [Abstract] [Full Text]  
  • Chew, E.-H., Lu, J., Bradshaw, T. D., Holmgren, A. (2008). Thioredoxin reductase inhibition by antitumor quinols: a quinol pharmacophore effect correlating to antiproliferative activity. FASEB J. 22: 2072-2083 [Abstract] [Full Text]  
  • Dammeyer, P., Damdimopoulos, A. E., Nordman, T., Jimenez, A., Miranda-Vizuete, A., Arner, E. S. J. (2008). Induction of Cell Membrane Protrusions by the N-terminal Glutaredoxin Domain of a Rare Splice Variant of Human Thioredoxin Reductase 1. J. Biol. Chem. 283: 2814-2821 [Abstract] [Full Text]  
  • Kobayashi-Miura, M., Shioji, K., Hoshino, Y., Masutani, H., Nakamura, H., Yodoi, J. (2007). Oxygen sensing and redox signaling: the role of thioredoxin in embryonic development and cardiac diseases. Am. J. Physiol. Heart Circ. Physiol. 292: H2040-H2050 [Abstract] [Full Text]  
  • Zhou, J., Damdimopoulos, A. E., Spyrou, G., Brune, B. (2007). Thioredoxin 1 and Thioredoxin 2 Have Opposed Regulatory Functions on Hypoxia-inducible Factor-1{alpha}. J. Biol. Chem. 282: 7482-7490 [Abstract] [Full Text]  
  • Patwari, P., Lee, R. T. (2007). Thioredoxins, Mitochondria, and Hypertension. Am. J. Pathol. 170: 805-808 [Abstract] [Full Text]  
  • Berndt, C., Lillig, C. H., Holmgren, A. (2007). Thiol-based mechanisms of the thioredoxin and glutaredoxin systems: implications for diseases in the cardiovascular system. Am. J. Physiol. Heart Circ. Physiol. 292: H1227-H1236 [Abstract] [Full Text]  
  • Sweat, T. A., Wolpert, T. J. (2007). Thioredoxin h5 Is Required for Victorin Sensitivity Mediated by a CC-NBS-LRR Gene in Arabidopsis. Plant Cell 19: 673-687 [Abstract] [Full Text]  
  • Liang, M., Pietrusz, J. L. (2007). Thiol-Related Genes in Diabetic Complications: A Novel Protective Role for Endogenous Thioredoxin 2. Arterioscler. Thromb. Vasc. Bio. 27: 77-83 [Abstract] [Full Text]  
  • Rohrbach, S., Gruenler, S., Teschner, M., Holtz, J. (2006). The thioredoxin system in aging muscle: key role of mitochondrial thioredoxin reductase in the protective effects of caloric restriction?. Am. J. Physiol. Regul. Integr. Comp. Physiol. 291: R927-R935 [Abstract] [Full Text]  
  • Tao, L., Jiao, X., Gao, E., Lau, W. B., Yuan, Y., Lopez, B., Christopher, T., RamachandraRao, S. P., Williams, W., Southan, G., Sharma, K., Koch, W., Ma, X. L. (2006). Nitrative Inactivation of Thioredoxin-1 and Its Role in Postischemic Myocardial Apoptosis. Circulation 114: 1395-1402 [Abstract] [Full Text]  
  • Turanov, A. A., Su, D., Gladyshev, V. N. (2006). Characterization of Alternative Cytosolic Forms and Cellular Targets of Mouse Mitochondrial Thioredoxin Reductase. J. Biol. Chem. 281: 22953-22963 [Abstract] [Full Text]  
  • Ohashi, S., Nishio, A., Nakamura, H., Kido, M., Ueno, S., Uza, N., Inoue, S., Kitamura, H., Kiriya, K., Asada, M., Tamaki, H., Matsuura, M., Kawasaki, K., Fukui, T., Watanabe, N., Nakase, H., Yodoi, J., Okazaki, K., Chiba, T. (2006). Protective roles of redox-active protein thioredoxin-1 for severe acute pancreatitis. Am. J. Physiol. Gastrointest. Liver Physiol. 290: G772-G781 [Abstract] [Full Text]  
  • Wang, D., Masutani, H., Oka, S.-i., Tanaka, T., Yamaguchi-Iwai, Y., Nakamura, H., Yodoi, J. (2006). Control of Mitochondrial Outer Membrane Permeabilization and Bcl-xL Levels by Thioredoxin 2 in DT40 Cells. J. Biol. Chem. 281: 7384-7391 [Abstract] [Full Text]  
  • Cenas, N., Prast, S., Nivinskas, H., Sarlauskas, J., Arner, E. S. J. (2006). Interactions of Nitroaromatic Compounds with the Mammalian Selenoprotein Thioredoxin Reductase and the Relation to Induction of Apoptosis in Human Cancer Cells. J. Biol. Chem. 281: 5593-5603 [Abstract] [Full Text]  
  • Jakupoglu, C., Przemeck, G. K. H., Schneider, M., Moreno, S. G., Mayr, N., Hatzopoulos, A. K., de Angelis, M. H., Wurst, W., Bornkamm, G. W., Brielmeier, M., Conrad, M. (2005). Cytoplasmic Thioredoxin Reductase Is Essential for Embryogenesis but Dispensable for Cardiac Development. Mol. Cell. Biol. 25: 1980-1988 [Abstract] [Full Text]  
  • Deroo, B. J., Hewitt, S. C., Peddada, S. D., Korach, K. S. (2004). Estradiol Regulates the Thioredoxin Antioxidant System in the Mouse Uterus. Endocrinology 145: 5485-5492 [Abstract] [Full Text]  
  • Conrad, M., Jakupoglu, C., Moreno, S. G., Lippl, S., Banjac, A., Schneider, M., Beck, H., Hatzopoulos, A. K., Just, U., Sinowatz, F., Schmahl, W., Chien, K. R., Wurst, W., Bornkamm, G. W., Brielmeier, M. (2004). Essential Role for Mitochondrial Thioredoxin Reductase in Hematopoiesis, Heart Development, and Heart Function. Mol. Cell. Biol. 24: 9414-9423 [Abstract] [Full Text]  
  • Lillig, C. H., Lonn, M. E., Enoksson, M., Fernandes, A. P., Holmgren, A. (2004). Short interfering RNA-mediated silencing of glutaredoxin 2 increases the sensitivity of HeLa cells toward doxorubicin and phenylarsine oxide. Proc. Natl. Acad. Sci. USA 101: 13227-13232 [Abstract] [Full Text]  
  • Hardt, S. E, Sadoshima, J. (2004). Negative regulators of cardiac hypertrophy. Cardiovasc Res 63: 500-509 [Abstract] [Full Text]  
  • Patenaude, A., Murthy, M. R. V., Mirault, M.-E. (2004). Mitochondrial Thioredoxin System: EFFECTS OF TrxR2 OVEREXPRESSION ON REDOX BALANCE, CELL GROWTH, AND APOPTOSIS. J. Biol. Chem. 279: 27302-27314 [Abstract] [Full Text]  
  • Zhang, R., Al-Lamki, R., Bai, L., Streb, J. W., Miano, J. M., Bradley, J., Min, W. (2004). Thioredoxin-2 Inhibits Mitochondria-Located ASK1-Mediated Apoptosis in a JNK-Independent Manner. Circ. Res. 94: 1483-1491 [Abstract] [Full Text]  
  • Elliott, N. A., Volkert, M. R. (2004). Stress Induction and Mitochondrial Localization of Oxr1 Proteins in Yeast and Humans. Mol. Cell. Biol. 24: 3180-3187 [Abstract] [Full Text]  
  • Katoh, I., Tomimori, Y., Ikawa, Y., Kurata, S.-i. (2004). Dimerization and Processing of Procaspase-9 by Redox Stress in Mitochondria. J. Biol. Chem. 279: 15515-15523 [Abstract] [Full Text]  
  • Watson, W. H., Yang, X., Choi, Y. E., Jones, D. P., Kehrer, J. P. (2004). Thioredoxin and Its Role in Toxicology. Toxicol Sci 78: 3-14 [Abstract] [Full Text]  
  • Leung, L., Kwong, M., Hou, S., Lee, C., Chan, J. Y. (2003). Deficiency of the Nrf1 and Nrf2 Transcription Factors Results in Early Embryonic Lethality and Severe Oxidative Stress. J. Biol. Chem. 278: 48021-48029 [Abstract] [Full Text]  
  • Fernandez, E. L., Gustafson, A.-L., Andersson, M., Hellman, B., Dencker, L. (2003). Cadmium-Induced Changes in Apoptotic Gene Expression Levels and DNA Damage in Mouse Embryos Are Blocked by Zinc. Toxicol Sci 76: 162-170 [Abstract] [Full Text]  
  • Nonn, L., Berggren, M., Powis, G. (2003). Increased Expression of Mitochondrial Peroxiredoxin-3 (Thioredoxin Peroxidase-2) Protects Cancer Cells Against Hypoxia and Drug-Induced Hydrogen Peroxide-Dependent Apoptosis. Mol Cancer Res 1: 682-689 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nonn, L.
Right arrow Articles by Powis, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nonn, L.
Right arrow Articles by Powis, G.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»